193 related articles for article (PubMed ID: 33369107)
1. Predictive value of protease-activated receptor-2 (PAR
He S; Xu M; Xiong Z; Hu Y; Huo Q; Lu J; Lin Y; Yang L
J Cell Mol Med; 2021 Feb; 25(3):1415-1424. PubMed ID: 33369107
[TBL] [Abstract][Full Text] [Related]
2. Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.
Yang L; Ma Y; Han W; Li W; Cui L; Zhao X; Tian Y; Zhou Z; Wang W; Wang H
J Biol Chem; 2015 Oct; 290(44):26627-37. PubMed ID: 26354435
[TBL] [Abstract][Full Text] [Related]
3. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
[TBL] [Abstract][Full Text] [Related]
6. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
[No Abstract] [Full Text] [Related]
7. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
8. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
9. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
[No Abstract] [Full Text] [Related]
11. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
Lin Q; Jiang Y; Zhou F; Zhang Y
Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
[No Abstract] [Full Text] [Related]
14. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
15. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
16. Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer.
Deng Y; Song Z; Huang L; Guo Z; Tong B; Sun M; Zhao J; Zhang H; Zhang Z; Li G
Aging (Albany NY); 2021 Nov; 13(22):24768-24785. PubMed ID: 34844217
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
18. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
[TBL] [Abstract][Full Text] [Related]
19. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Wang L; Qu H; Ma X; Liu X
Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation.
Ma Y; Bao-Han W; Lv X; Su Y; Zhao X; Yin Y; Zhang X; Zhou Z; MacNaughton WK; Wang H
PLoS One; 2013; 8(8):e72383. PubMed ID: 23991105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
